Cite
Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
MLA
Zhu, Xiaopeng, et al. “Berberine Attenuates Nonalcoholic Hepatic Steatosis through the AMPK-SREBP-1c-SCD1 Pathway.” Free Radical Biology & Medicine, vol. 141, Sept. 2019, pp. 192–204. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2019.06.019.
APA
Zhu, X., Bian, H., Wang, L., Sun, X., Xu, X., Yan, H., Xia, M., Chang, X., Lu, Y., Li, Y., Xia, P., Li, X., & Gao, X. (2019). Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Free Radical Biology & Medicine, 141, 192–204. https://doi.org/10.1016/j.freeradbiomed.2019.06.019
Chicago
Zhu, Xiaopeng, Hua Bian, Liu Wang, Xiaoyang Sun, Xi Xu, Hongmei Yan, Mingfeng Xia, et al. 2019. “Berberine Attenuates Nonalcoholic Hepatic Steatosis through the AMPK-SREBP-1c-SCD1 Pathway.” Free Radical Biology & Medicine 141 (September): 192–204. doi:10.1016/j.freeradbiomed.2019.06.019.